SKI Market

A+| A| A-|

Indian Indices

Sensex

76,886.91 -416.72
( -0.54%)

Global Indices

Nasdaq

49,198.35 -53.37
(-0.11%)

Dow Jones

7,195.79 9.71
(0.14%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,331.11 -47.97
(-0.46%)

Forex

USD-INR

93.91 -0.14
(-0.15%)

EUR-INR

110.02 0.03
(0.03%)

GBP-INR

127.00 0.16
(0.13%)

JPY-INR

0.59 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.4359033

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

78.77

415

EPS(TTM)

Face Value()

Div & Yield %

0.97

Back

MKVentures Capital consolidated net profit declines 56.77% in the December 2025 quarter

Feb 13,2026

Net profit of MKVentures Capital declined 56.77% to Rs 2.33 crore in the quarter ended December 2025 as against Rs 5.39 crore during the previous quarter ended December 2024. Sales declined 64.30% to Rs 1.76 crore in the quarter ended December 2025 as against Rs 4.93 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.76	4.93	-64
OPM %	138.64	149.49	-
PBDT	2.41	7.28	-67
PBT	2.35	7.18	-67
NP	2.33	5.39	-57

76,886.91 -416.72 ( -0.54%)

49,198.35 -53.37 (-0.11%)

7,195.79 9.71 (0.14%)

59,839.06 -698.30 (-1.15%)

10,331.11 -47.97 (-0.46%)

93.91 -0.14 (-0.15%)

110.02 0.03 (0.03%)

127.00 0.16 (0.13%)

0.59 0.00 (-0.03%)